Reactive Arthritis

Reactive arthritis is a medical condition that is typically characterized by a combination of three symptoms: urethritis, conjunctivitis, and seronegative arthritis. This type of arthritis usually affects the large weight-bearing joints, such as the knee and ankle, but not all three symptoms are always present in a patient. Reactive arthritis can be triggered by either a sexually transmitted infection or a dysenteric infection. One of the most notable signs of this condition is the appearance of a brown macular rash known as keratoderma blennorrhagica, which is usually seen on the palms and soles.

The main treatment for reactive arthritis involves the use of non-steroidal anti-inflammatory drugs (NSAIDs). These medications can help to alleviate the pain and inflammation associated with the condition. Additionally, antibiotics may be prescribed to individuals who have recently experienced a non-gonococcal venereal infection. This can help to reduce the likelihood of that person developing reactive arthritis. Overall, the symptoms and treatment options for reactive arthritis can help individuals to manage this condition and improve their quality of life.

Differentiating Autoantibodies in Connective Tissue Diseases

Connective tissue diseases are a group of autoimmune disorders that affect various parts of the body. Differentiating between these diseases can be challenging, but autoantibodies can provide valuable clues. Here are some common autoantibodies and the connective tissue diseases they are associated with:

1. Anti-centromere antibody: This antibody is most likely to be present in limited systemic sclerosis (CREST).

2. Anti-Scl-70: This antibody is found in diffuse systemic sclerosis.

3. Anti-RNP antibody: This antibody is found in mixed connective tissue disease.

4. Anti-Ro antibody: This antibody is classically positive in Sjögren’s syndrome or systemic lupus erythematosus.

5. Anti-Jo-1 antibody: This antibody is commonly raised in polymyositis.

By identifying the specific autoantibodies present in a patient, healthcare providers can better diagnose and manage connective tissue diseases.

The Role of Human Leukocyte Antigens in Autoimmune Diseases

Human leukocyte antigens (HLAs) play a crucial role in the development of autoimmune diseases. Different HLAs are associated with specific autoimmune conditions. For example, HLA-B27 is present in 90% of patients with ankylosing spondylitis, as well as reactive arthritis and acute anterior uveitis. HLA-Cw6 is associated with psoriasis vulgaris, while HLA-B8 is linked to hyperthyroidism (Graves’ disease). HLA-DR4 is associated with rheumatoid arthritis and type 1 diabetes mellitus, and HLA-DR2 is linked to systemic lupus erythematosus (SLE) in Japanese people, multiple sclerosis, and Goodpasture syndrome. Understanding the role of HLAs in autoimmune diseases can help with diagnosis and treatment.

Understanding Different Types of Arthritis: Ankylosing Spondylitis, Osteoarthritis, Prolapsed Intervertebral Disc, Reactive Arthritis, and Rheumatoid Arthritis

Ankylosing spondylitis is a type of arthritis that commonly affects the sacroiliac joints, causing pain and stiffness that improves with exercise. It may also involve inflammation of the colon or ileum, which can lead to inflammatory bowel disease in some cases. The presence of the HLA-B27 gene is often associated with ankylosing spondylitis. Osteoarthritis, on the other hand, is unlikely in younger individuals and is not linked to bowel disease. Prolapsed intervertebral disc is characterized by severe lower back pain and sciatica, but stiffness is not a typical symptom. Reactive arthritis is usually triggered by a recent GI illness or sexually transmitted infection and is associated with arthritis, a psoriatic type rash, and conjunctivitis. Finally, rheumatoid arthritis rarely affects the sacroiliac joints as the primary site. It is important to understand the differences between these types of arthritis to receive proper diagnosis and treatment.

Polymyalgia rheumatica is an inflammatory disease that causes pain and stiffness in the shoulder and pelvic girdle muscles, along with systemic symptoms such as fever and weight loss. It is often associated with giant cell arthritis. Diagnosis can be difficult, but response to a moderate dose of steroids is a useful indicator. Non-steroidal anti-inflammatories are not recommended. Other inflammatory conditions should be excluded, such as rheumatoid arthritis, systemic lupus erythematosus, polymyositis, and polyarteritis nodosa.

Common Hand and Wrist Pathologies

The hand and wrist are common sites of pathology, particularly in postmenopausal women. Osteoarthritis frequently affects the first carpometacarpal joint, causing tenderness, stiffness, crepitus, swelling, and pain on thumb abduction. This can lead to squaring of the hand, radial subluxation of the metacarpal, and atrophy of the thenar muscles.

Scaphoid fractures are also relatively common, often resulting from a fall onto an outstretched hand. The proximal portion of the scaphoid lacks its own blood supply, which can lead to avascular necrosis if a fracture isolates it from the rest of the bone. This produces pain and tenderness on the radial side of the wrist, typically in the anatomical snuffbox, worsened by wrist movement.

De Quervain’s tenosynovitis is another common pathology, characterized by stenosing tenosynovitis of the first dorsal compartment of the wrist. It presents with pain, swelling, and tenderness on the radial aspect of the wrist. Treatment typically involves splinting, with or without corticosteroid injection.

Osteoarthrosis and Common Deformities in the Hand

Osteoarthrosis (OA) is a prevalent type of arthritis that often affects the hand. Upon examination of the joints, it is common to find small bone spurs known as nodes on the tops of joints. These nodes can take on different names depending on their location. For instance, if they occur at the joint next to the fingernail, they are called Heberden’s nodes. On the other hand, if they occur at the PIP joints, they are referred to as Bouchard’s nodes. It is worth noting that shoulder joint involvement is rare in OA.

Differentiating Connective Tissue Pathologies: Histological Characteristics

Connective tissue pathologies can present with a variety of clinical features, making it important to understand their histological characteristics for accurate diagnosis.

Rheumatoid arthritis is characterized by swan neck deformity, subcutaneous nodules, and enlarged knuckles. The histological composition of subcutaneous nodules is areas of fibrinoid necrosis surrounded by palisading epithelioid cells.

Gouty tophi, on the other hand, present as an amorphous crystalline mass surrounded by macrophages.

A cystic space caused by myxoid degeneration of connective tissue is more typical of a ganglion cyst.

Nodular tenosynovitis is a well-encapsulated nodule of polygonal cells within a tendon sheath.

Lastly, pigmented villonodular synovitis is characterized by a darkly pigmented synovium with an exuberant, villous growth.

Understanding the histological characteristics of these connective tissue pathologies can aid in accurate diagnosis and appropriate management.

Types of Arthritis and Infections that can Cause Tenosynovitis

Tenosynovitis is a condition where the tendon sheath becomes inflamed, causing pain and swelling. It can be caused by various types of arthritis and infections. Here are some of the most common causes:

Systemic Sclerosis: This autoimmune disease causes fibrosis of connective tissue, resulting in hard and thickened skin, swollen digits, and Raynaud’s phenomenon. Tenosynovitis in systemic sclerosis is non-tender and without swelling of the tendons.

Rheumatoid Arthritis: Tenosynovitis due to rheumatoid arthritis causes pain and swelling of tendons. It usually involves the interphalangeal, metacarpophalangeal, and wrist joints, and can cause deformities such as swan neck and Boutonnière’s deformity.

Gout: Gout can cause tenosynovitis, which is very painful and presents with redness and swollen tendons. It typically affects the metatarsophalangeal joints.

Disseminated Gonococcal Infection: This infection can cause acute migratory tenosynovitis, especially in younger adults. Women may be asymptomatic, while men may present with urethral discharge or dysuria.

Reactive Arthritis: This type of arthritis causes pain and swelling of tendons, commonly affecting the knees or sacrum. It is an acutely inflammatory process and would therefore be swollen and tender.

In conclusion, tenosynovitis can be caused by various types of arthritis and infections, and it is important to identify the underlying cause in order to provide appropriate treatment.

Understanding HLA and Autoimmune Diseases

HLA-B27 is a genetic marker associated with ankylosing spondylitis, an autoimmune disease that primarily affects the spine. This disease is more common in males and typically presents in the 20s and 30s. Other autoimmune manifestations, such as anterior uveitis, can also occur in individuals with HLA-B27. Additionally, young men with this genetic marker may be prone to reactive arthritis after chlamydia or gonorrhoeal urethritis.

Rheumatoid factor, on the other hand, is not associated with HLA-B27 or ankylosing spondylitis. While stiffness that improves with exercise may be seen in rheumatoid arthritis, this disease typically affects peripheral joints and does not lead to calcification of the anterior spinal ligament.

Other HLA markers are associated with different autoimmune diseases. HLA-DR3 is linked to type 1 diabetes mellitus, HLA-DR5 is associated with pernicious anaemia and Hashimoto’s thyroiditis, and HLA-B8 is linked to Graves’ disease. Understanding these genetic markers can aid in the diagnosis and management of autoimmune diseases.

Behçet’s Syndrome

Behçet’s syndrome is a medical condition that is characterized by a range of symptoms. These symptoms include recurrent oral and genital ulcers, uveitis, seronegative arthritis, central nervous system symptoms, fever, thrombophlebitis, erythema nodosum, abdominal symptoms, and vasculitis. The condition is often marked by periods of exacerbations and remissions, which can make it difficult to manage.

One of the most common symptoms of Behçet’s syndrome is the presence of oral and genital ulcers that recur over time. These ulcers can be painful and may make it difficult to eat or engage in sexual activity. Uveitis, or inflammation of the eye, is another common symptom of the condition. This can cause redness, pain, and sensitivity to light.

Seronegative arthritis, which is a type of arthritis that does not show up on blood tests, is also associated with Behçet’s syndrome. This can cause joint pain and stiffness, as well as swelling and inflammation. Central nervous system symptoms, such as headaches, confusion, and seizures, may also occur.

Other symptoms of Behçet’s syndrome include fever, thrombophlebitis, erythema nodosum, abdominal symptoms, and vasculitis. These symptoms can vary in severity and may come and go over time. Managing Behçet’s syndrome can be challenging, but with proper treatment and care, many people are able to live full and active lives.

Understanding the Diagnosis of Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR) is a condition that causes pain and stiffness in proximal muscle groups, often accompanied by systemic symptoms. While other potential diagnoses such as infections or neoplasia should be considered, PMR is typically characterised by raised levels of inflammatory markers, particularly erythrocyte sedimentation rate (ESR). Treatment with corticosteroids usually results in rapid improvement, and lack of response to steroids may indicate a need to re-evaluate the diagnosis. Autoantibody screening and nerve conduction velocity tests are not helpful in diagnosing PMR, while muscle biopsy may be performed to exclude polymyositis. A temporal artery biopsy may be considered if the patient has symptoms of giant cell arthritis.

NSAIDs for Gout Treatment

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat acute attacks of gout. Among the NSAIDs, indomethacin is the most frequently prescribed due to its potent anti-inflammatory properties. However, it is important to note that aspirin and aspirin-containing products should be avoided during acute gout attacks as they can actually trigger or worsen the condition. Therefore, it is crucial to consult with a healthcare provider before taking any medication for gout, especially during an acute attack. Proper use of NSAIDs can help alleviate the pain and inflammation associated with gout, improving the patient’s quality of life.

Psoriatic Arthritis: Common Presentations and Misconceptions

Psoriatic arthritis is a type of arthritis that affects some individuals with psoriasis. While it can present in various ways, there are some common misconceptions about its symptoms. Here are some clarifications:

1. Arthritis mutilans is a severe form of psoriatic arthritis, not a separate condition.

2. Psoriatic arthritis can have a rheumatoid-like presentation, but not an osteoarthritis-like one.

3. The most common presentation of psoriatic arthritis is distal interphalangeal joint involvement, not proximal.

4. Psoriatic spondylitis is a type of psoriatic arthritis that affects the spine, not ankylosing spondylitis.

5. Asymmetrical oligoarthritis is a common presentation of psoriatic arthritis, not symmetrical oligoarthritis.

Understanding these presentations can help with early diagnosis and appropriate treatment of psoriatic arthritis.

Potential Side Effects of Common Rheumatoid Arthritis Medications

Methotrexate, a commonly prescribed medication for rheumatoid arthritis, has been known to cause acute pneumonitis and interstitial lung disease. Although this is a rare complication, it can be fatal and should be closely monitored. Azathioprine, another medication used to treat rheumatoid arthritis, can lead to bone marrow suppression and increase the risk of infection. Cyclosporin, often used in combination with other medications, can cause neurological and visual disturbances. Hydroxychloroquine, while generally well-tolerated, can lead to abdominal pain and visual disturbances in cases of toxicity. Sulfasalazine, another medication used to treat rheumatoid arthritis, can affect liver function tests and cause bone marrow suppression, requiring careful monitoring.

It is important for patients to be aware of the potential side effects of their medications and to communicate any concerns with their healthcare provider. Regular monitoring and follow-up appointments can help to identify and manage any adverse effects. With proper management, the benefits of these medications can outweigh the risks for many patients with rheumatoid arthritis.

Understanding Autoimmune Disorders: Differentiating Between Ankylosing Spondylitis, SLE, and Rheumatoid Arthritis

Autoimmune disorders can be difficult to diagnose due to their overlapping symptoms. However, certain laboratory tests can help differentiate between them.

One such test is the human leukocyte antigen (HLA)-B27, which is associated with ankylosing spondylitis. This autoimmune disorder primarily affects men and is characterized by back stiffness that improves throughout the day, sacroiliitis, and a bamboo spine on radiography.

On the other hand, positive antinuclear antibodies and anti-double-stranded DNA antibodies are associated with systemic lupus erythematosus (SLE). Patients with SLE may experience joint pain, skin rashes, and organ involvement.

Lastly, positive anti-cyclic citrullinated peptide (CCP) antibodies are associated with rheumatoid arthritis. This autoimmune disorder is characterized by joint pain, swelling, and stiffness, and can lead to joint deformities if left untreated.

In summary, understanding the specific laboratory tests associated with different autoimmune disorders can aid in their diagnosis and treatment.

Differential Diagnosis for a Young Man with Purpura and Haematuria

The patient in question presents with a purpuric rash on the back, buttocks, and extensor surfaces of the lower limbs, as well as haematuria. The following is a differential diagnosis of possible conditions that could be causing these symptoms.

Henoch–Schönlein purpura (HSP)
The clinical presentation is entirely typical of HSP, a vasculitic process that results in a purpuric rash and haematuria. It should be noted that platelet numbers are usually normal or raised in HSP, so thrombocytopaenia is not expected.

Haemophilia A
This condition is not likely as it results in joint and muscle bleeding, which is not present in this case. Additionally, haemophilia would not cause haematuria.

Idiopathic thrombocytopaenic purpura (ITP)
While purpura is a symptom of ITP, a reduced platelet count is typically present. Without a discussion of platelet levels, it is difficult to justify a diagnosis of ITP. Additionally, ITP would not result in haematuria.

Leukaemia
If acute leukaemia were causing the symptoms, thrombocytopaenia might be expected. However, the clinical presentation is more compatible with HSP, and thrombocytopaenia alone would not result in haematuria.

Thalassaemia trait
There is no indication in the history to suggest this condition, and it would not result in purpura. Thalassaemia trait is typically asymptomatic.

In conclusion, the patient’s symptoms are most consistent with HSP, a vasculitic process that results in a purpuric rash and haematuria.

Treatment Options for Rheumatoid Disease: A Comparison of Biological Therapies and DMARDs

Rheumatoid disease can be a debilitating condition that requires careful management. When standard disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief, biological therapies may be prescribed. Infliximab, adalimumab, and etanercept are some of the contemporary biological therapies available. Infliximab, in particular, is often co-prescribed with methotrexate, although it may cause a reversible lupus-like syndrome and tuberculosis reactivation.

Combining gold, leflunomide, and methotrexate is unlikely to help patients who have already failed DMARD therapy. Azathioprine may be considered in severe cases, but biological therapy is the preferred treatment when intensive DMARD therapy fails. The combination of gold and penicillamine is a viable option for patients who meet the criteria for biological therapy, according to National Institute for Health and Care Excellence (NICE) guidelines. DMARD monotherapy, such as leflunomide, is only recommended when dual therapy is contraindicated.

In summary, the choice of treatment for rheumatoid disease depends on the severity of the condition and the patient’s response to previous therapies. Biological therapies may offer relief for patients who have failed DMARD therapy, but careful monitoring for potential side effects is necessary.

Ocular Manifestations of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory polyarthropathy that primarily affects small joints, causing symmetrical joint tenderness and swelling. It is an autoimmune disease with genetic and environmental risk factors. RA can result in marked physical disability, and extra-articular features are more common in rheumatoid factor-positive patients with long-standing disease. Ocular manifestations of RA include keratoconjunctivitis sicca, also known as dry eye syndrome, which is the most common ocular extra-articular manifestation. Scleromalacia perforans, a thinning of the sclera, is associated with RA but presents less often than keratoconjunctivitis sicca. Episcleritis and scleritis are also associated with RA but are less common than keratoconjunctivitis sicca. Orbital apex syndrome may involve the optic nerve, causing a palsy, but this is very rare. It is important for healthcare providers to be aware of these ocular manifestations and monitor patients with RA for any changes in their vision or eye health.

Differential Diagnosis for a Patient with Splenomegaly, Neutropenia, and Active Rheumatoid Disease

Felty’s Syndrome:
The patient’s symptoms of splenomegaly, neutropenia, and active rheumatoid disease suggest Felty’s syndrome. This condition is thought to occur due to the sequestration and destruction of granulocytes, potentially caused by reduced granulocyte growth factors and autoantibodies/immune complexes formed against them. Felty’s syndrome affects 1-3% of patients with rheumatoid arthritis and has a higher prevalence in females. Treatment typically involves the use of methotrexate as a disease-modifying anti-rheumatic drug, with splenectomy reserved as a last resort.

Lymphoma:
While lymphoma can present with lymphadenopathy, the absence of B-symptoms such as fever, night sweats, weight loss, or pruritus makes this diagnosis less likely in this case.

Myeloma:
Myeloma often presents with anaemia and bone pain, as well as hypercalcaemia. Serum and urine electrophoresis are important investigations for this condition.

Sarcoidosis:
Sarcoidosis commonly presents with respiratory symptoms such as wheeze, cough, and shortness of breath, as well as erythema nodosum and lymphadenopathy on examination. While the patient has a history of lower respiratory tract infections, her response to clarithromycin suggests an infective cause rather than sarcoidosis.

Tuberculosis:
The patient does not have any clinical features or risk factors for tuberculosis.

Medication Combinations for Treating Rheumatoid Arthritis

When treating rheumatoid arthritis, the first-line medication is a DMARD monotherapy with methotrexate. Short-term steroids may also be used in combination with DMARD monotherapy to induce remission. Hydroxychloroquine is another medication that can be used, but patients should be closely monitored for visual changes as retinopathy and corneal deposits are common side effects.

Etanercept is not a first-line treatment for rheumatoid arthritis, and methotrexate should not be given in combination with a TNF-alpha inhibitor like etanercept. Methotrexate plus sulfasalazine is an appropriate medication combination for treating rheumatoid arthritis, but regular eye checks are not required as neither medication affects vision.

If a patient has failed treatment with methotrexate, sulfasalazine plus hydroxychloroquine may be a regimen to consider trialling. However, it is important to note that new-onset rheumatoid arthritis should be treated with a DMARD monotherapy first line, with the addition of another DMARD like methotrexate as the first-line option.

Understanding Fibromyalgia and Differential Diagnosis

Fibromyalgia is a functional condition that affects voluntary muscles, commonly presenting in females aged 20-40 years. It is characterized by multiple trigger points over soft tissues in the neck, intrascapular region, and spine, along with poor sleep patterns and fatigue. While there is no known cure, patients are encouraged to establish a regular sleep pattern and participate in a graded exercise program. Differential diagnosis is important to exclude other rheumatological conditions that may present similarly but have different treatment options. Polymyalgia rheumatica, polymyositis, hypothyroidism, and systemic lupus erythematosus are some of the conditions that need to be ruled out. Steroids are the mainstay of treatment for polymyalgia rheumatica, while hypothyroidism presents with different symptoms such as constipation, dry hair, and weight gain. Systemic lupus erythematosus typically presents with a butterfly rash over the face and other symptoms such as anaemia, pleuritic chest pain, and haematuria.

Characteristics of Different Arthritis Types

Psoriatic arthritis is a type of arthritis that commonly affects the distal interphalangeal (DIP) joints. It is often accompanied by psoriasis around the adjacent nail, and other joint involvement is typically more asymmetric than in rheumatoid arthritis. On the other hand, Reactive arthritis is characterized by uveitis, urethritis, and arthritis that does not involve the DIP. Gout, another type of arthritis, does not typically affect the DIP either. While rheumatoid arthritis can occasionally affect the DIP, it is classically a MCP and PIP arthritis. Lastly, bursitis is a pathology of the bursa, not the joint itself. the characteristics of different types of arthritis can aid in proper diagnosis and treatment.

Differential Diagnosis for a Patient with Shoulder and Pelvic Girdle Pain

Polymyalgia rheumatica (PMR) is a likely diagnosis for a patient presenting with shoulder and pelvic girdle pain without muscle weakness and a markedly raised ESR. Rapid improvement of symptoms with corticosteroids and a subsequent fall in ESR confirms the diagnosis. Temporal arthritis, a vasculitis associated with PMR, should also be considered in patients over 50 presenting with headache, vision loss, and jaw claudication. Myositis and dermatomyositis are less likely diagnoses due to the patient’s normal CK and lack of muscle weakness. Rheumatoid arthritis is unlikely given the patient’s age and the classic joint involvement pattern.

Heberden’s Nodules

Heberden’s nodules are bony growths that form around the joints at the end of the fingers. These nodules are most commonly found on the second and third fingers and are caused by calcification of the cartilage in the joint. This condition is often associated with osteoarthritis and is more common in women. Heberden’s nodules typically develop in middle age.

Overall, Heberden’s nodules can be a painful and uncomfortable condition for those who experience them. However, the causes and symptoms of this condition can help individuals seek appropriate treatment and manage their symptoms effectively. With proper care and attention, it is possible to minimize the impact of Heberden’s nodules on daily life.

The symptoms described suggest a diagnosis of ankylosing spondylitis, a chronic form of seronegative spondyloarthropathy that primarily affects the axial skeleton. Diagnosis is made using the modified New York criteria, which includes clinical and radiological criteria. HLA-B27 and sacroiliitis on MRI play a major role in the recently proposed ASAS diagnostic algorithm. Radiographic sacroiliitis is required for eligibility for anti-TNF treatment. Other conditions, such as pseudogout, Lyme disease, osteoarthritis, and rheumatoid arthritis, are unlikely diagnoses. Timely diagnosis requires a high index of suspicion.

The patient in this scenario has systemic lupus erythematosus (SLE) with mild symptoms, primarily affecting the joints and skin. The first-line treatment for this type of SLE is hydroxychloroquine, which can induce remission and reduce recurrence. However, patients on this medication must be monitored for drug-induced retinopathy. Methotrexate may be used in more severe cases with active joint synovitis. Sun avoidance is important to prevent flares, but it is not enough to treat the patient’s current symptoms. Infliximab is not typically used to treat SLE, and rituximab is reserved for last-line therapy. Azathioprine is commonly used as a steroid-sparing agent in SLE, but hydroxychloroquine is more appropriate for this patient’s current presentation. The main adverse effect of azathioprine is bone marrow suppression, which can be life-threatening in some patients.

Ankylosing Spondylitis and Cardiac Manifestations

Ankylosing spondylitis (AS) is a systemic disorder that affects multiple systems in the body. One of the extra-articular manifestations of AS is cardiac involvement, which can lead to heart block and aortic regurgitation. Chronic aortic regurgitation can cause left ventricular hypertrophy, resulting in deep S in V1 and tall R in V5. A-V dissociation is the ECG manifestation of heart block. Mortality rates are higher in patients with AS, with circulatory disease being the most common cause of death.

P-pulmonale is not a typical manifestation of AS, but it can occur in cases of pulmonary hypertension when the right atrium is enlarged. Pulmonary fibrosis, which can occur in AS, can theoretically lead to pulmonary hypertension and p-pulmonale. Right bundle branch block is a non-specific ECG finding that can occur without any heart disease or in conditions such as atrial septal defect, ischemic heart disease, or pulmonary embolism.

In conclusion, AS is a systemic disorder that can affect multiple systems in the body, including the heart. Cardiac involvement can lead to heart block and aortic regurgitation, which can cause left ventricular hypertrophy. Mortality rates are higher in patients with AS, with circulatory disease being the most common cause of death. While p-pulmonale is not a typical manifestation of AS, it can occur in cases of pulmonary hypertension. Right bundle branch block is a non-specific ECG finding that can occur in various conditions.

Treatment Options for Severe Rheumatoid Arthritis

Severe rheumatoid arthritis can be a challenging condition to manage, especially when conventional disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief. In such cases, biological therapies may be recommended. Here are some treatment options for severe rheumatoid arthritis:

Enrol in Biological Therapy Programme
Patients with highly active disease despite trying three previous agents for a therapeutic treatment duration may be candidates for biological treatments. TNF-alpha inhibitors and anti-CD20 are examples of biological treatments that are routinely used in the UK.

Maintain on Steroids and Add a Bisphosphonate
Short-term treatment with glucocorticoids may be offered to manage flares in people with recent-onset or established disease. However, long-term treatment with glucocorticoids should only be continued when the long-term complications of glucocorticoid therapy have been fully discussed and all other treatment options have been offered.

Commence Leflunomide
Severe disease that has not responded to intensive therapy with a combination of conventional DMARDs should be treated with biological agents. Leflunomide is one of the DMARDs that can be used in combination therapy.

Use Methotrexate/Leflunomide Combination
Patients who have not responded to intensive DMARD therapy may be prescribed a biological agent, as per NICE guidelines. Methotrexate and leflunomide are two DMARDs that can be used in combination therapy.

Avoid Commencing Penicillamine
DMARD monotherapy is only recommended if combination DMARD therapy is not appropriate. Patients without contraindications to combination therapy should not be prescribed penicillamine.

Treatment Options for Fibromyalgia Patients

Fibromyalgia is a chronic condition that causes widespread pain, increased sensitivity to pain, and psychological symptoms. Treatment options can be divided into generic and patient-focused treatments. Aerobic exercise is a first-line, generic treatment that has been shown to improve symptoms of pain and physical function. Cognitive behavioral therapy (CBT) is a patient-focused treatment that may be considered for patients with pain-related depression, anxiety, catastrophizing, and/or passive or active coping strategies. Anaerobic exercise should be avoided as it may increase inflammation and oxidative stress. Duloxetine and pregabalin are pharmacotherapy options for patients with severe pain or sleep disturbance, but only after non-pharmacological treatments have failed. It is important to tailor treatment to each patient’s individual needs.

Treatment Options for Fibromyalgia Patients